NCI's RAS Initiative explores innovative methods for attacking the proteins encoded by mutant sorts of the KRAS gene. A few other KRAS G12C inhibitors are over the heels of sotorasib and therefore are at this time remaining analyzed in scientific trials. And you can find possible more to return.